168650-46-2

168650-46-2 structure

Name: (Asp371)-Tyrosinase (369-377) (human) acetate salt
Chemical Name: L-Tyrosyl-L-Methionyl-L-alpha-Aspartylglycyl-L-Threonyl-L-Methionyl-L-Seryl-L-Glutaminyl-L-Valine
CAS Number: 168650-46-2
Molecular Formula: C₄₂H₆₆N₁₀O₁₆S₂
Molecular Weight: 1031.161
Catalog: Research Areas Cancer
Create Date: 2018-12-23 19:17:20
Modify Date: 2025-08-26 07:13:14
Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy[1][2].

Name	L-Tyrosyl-L-Methionyl-L-alpha-Aspartylglycyl-L-Threonyl-L-Methionyl-L-Seryl-L-Glutaminyl-L-Valine
Synonyms	L-Valine, L-tyrosyl-L-methionyl-L-α-aspartylglycyl-L-threonyl-L-methionyl-L-seryl-L-glutaminyl- L-Tyrosyl-L-methionyl-L-α-aspartylglycyl-L-threonyl-L-methionyl-L-seryl-L-glutaminyl-L-valine Tyrosinase YMDGTMSQV (Asp371)-Tyrosinase (369-377) (human)

Description	Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
References	[1]. Guillaume B, et al. Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol. 2012 Oct 1;189(7):3538-47. [2]. Mitchell MS, et al. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J Clin Oncol. 2002 Feb 15;20(4):1075-86.

RIDADR	NONH for all modes of transport